GeoVax Labs, Inc. also files under GOVX.OB; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Kollintzas Dean G | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Jun 17, 2026 | Morgan Jayne | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | Spencer John N JR | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | Newman Mark J | Chief Scientific Officer | Grant(A) | 18K | — | $0 |
| Jun 17, 2026 | Reynolds Mark | CFO | Grant(A) | 18K | — | $0 |
| Jun 17, 2026 | Lemerond Nicole | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | Sharkey John W. | VP, Business Development | Grant(A) | 18K | — | $0 |
| Jun 17, 2026 | McNally Robert T | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | Chase Randal D | Director | Grant(A) | 6K | — | $0 |
| Jun 17, 2026 | Dodd David A | President, CEO, Director | Grant(A) | 29K | — | $0 |
| Oct 17, 2025 | Spencer John N JR | Director | Buy(P) | 10K | $0.55 | $6K |
| Aug 7, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 1K | $0.67 | $742 |
| Jun 5, 2025 | Chase Randal D | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Spencer John N JR | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Kollintzas Dean G | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | McNally Robert T | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Morgan Jayne | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Dodd David A | President, CEO, Director | Grant(A) | 186K | — | $0 |
| Jun 5, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Reynolds Mark | CFO | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Newman Mark J | Chief Scientific Officer | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Lemerond Nicole | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Sharkey John W. | VP, Business Development | Grant(A) | 70K | — | $0 |
| Apr 10, 2025 | Spencer John N JR | Director | Buy(P) | 10K | $0.98 | $10K |
| Apr 10, 2025 | Sharkey John W. | VP, Business Development | Buy(P) | 6K | $0.99 | $6K |
| Apr 1, 2025 | Dodd David A | President, CEO, Director | Buy(P) | 10K | $1.08 | $11K |
| Mar 31, 2025 | Reynolds Mark | CFO | Buy(P) | 7K | $1.08 | $7K |
| Aug 12, 2024 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Chase Randal D | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Dodd David A | President, CEO, Director | Grant(A) | 35K | — | $0 |
| Aug 12, 2024 | Newman Mark J | Chief Scientific Officer | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Reynolds Mark | CFO | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | McNally Robert T | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Sharkey John W. | VP, Business Development | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Lemerond Nicole | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Morgan Jayne | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Kollintzas Dean G | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Spencer John N JR | Director | Grant(A) | 8K | — | $0 |
| Aug 9, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 8K | $1.95 | $16K |
| Feb 22, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 8K | $2.27 | $19K |
| Feb 21, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 520 | $2.15 | $1K |
| Feb 7, 2024 | Reynolds Mark | CFO | Buy(P) | 2K | $2.77 | $6K |
| Dec 22, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 7K | $0.36 | $2K |
| Sep 25, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 10K | $0.52 | $5K |
| Aug 25, 2023 | Dodd David A | President, CEO, Director | Buy(P) | 35K | $0.57 | $20K |
| Aug 18, 2023 | Reynolds Mark | CFO | Buy(P) | 10K | $0.52 | $5K |
| Aug 1, 2023 | Reynolds Mark | CFO | Grant(A) | 100K | — | $0 |
| Aug 1, 2023 | Spencer John N JR | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Morgan Jayne | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | McNally Robert T | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Chase Randal D | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Kollintzas Dean G | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Lemerond Nicole | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Aug 1, 2023 | Sharkey John W. | VP, Business Development | Grant(A) | 100K | — | $0 |
| Aug 1, 2023 | Dodd David A | President, CEO, Director | Grant(A) | 250K | — | $0 |
| Aug 1, 2023 | Newman Mark J | Chief Scientific Officer | Grant(A) | 100K | — | $0 |
| Apr 24, 2023 | Dodd David A | President, CEO, Director | Buy(P) | 32K | $0.64 | $20K |
| Apr 20, 2023 | Reynolds Mark | CFO | Buy(P) | 8K | $0.63 | $5K |
| Sep 21, 2022 | Chase Randal D | Director | Buy(P) | 10K | $1.10 | $11K |
| Jul 1, 2022 | Sharkey John W. | VP, Business Development | Buy(P) | 1K | $0.82 | $820 |
| Jun 27, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 4K | $1.12 | $5K |
| Jun 21, 2022 | Chase Randal D | Director | Buy(P) | 10K | $1.21 | $12K |
| May 5, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 10K | $0.72 | $7K |
| May 4, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 5K | $0.71 | $4K |
| Dec 7, 2021 | Dodd David A | President, CEO, Director | Grant(A) | 103K | — | $0 |
| Dec 7, 2021 | Reynolds Mark | CFO | Grant(A) | 48K | — | $0 |
| Dec 7, 2021 | Spencer John N JR | Director | Grant(A) | 25K | — | $0 |
| Dec 7, 2021 | McNally Robert T | Director | Grant(A) | 25K | — | $0 |
| Dec 7, 2021 | Newman Mark J | Chief Scientific Officer | Grant(A) | 26K | — | $0 |
| Dec 7, 2021 | Kollintzas Dean G | Director | Grant(A) | 25K | — | $0 |
| Dec 7, 2021 | Chase Randal D | Director | Grant(A) | 25K | — | $0 |
| Aug 11, 2021 | Spencer John N JR | Director | Grant(A) | 25K | — | $0 |
| Aug 11, 2021 | Dodd David A | President, CEO, Director | Grant(A) | 273K | — | $0 |
| Aug 11, 2021 | Chase Randal D | Director | Grant(A) | 25K | — | $0 |
| Aug 11, 2021 | Reynolds Mark | CFO | Grant(A) | 128K | — | $0 |
| Aug 11, 2021 | Newman Mark J | Chief Scientific Officer | Grant(A) | 35K | — | $0 |
| Aug 11, 2021 | Kollintzas Dean G | Director | Grant(A) | 25K | — | $0 |
| Aug 11, 2021 | McNally Robert T | Director | Grant(A) | 25K | — | $0 |
| Sep 29, 2020 | McNally Robert T | Director | Buy(P) | 54K | — | $0 |
| Sep 29, 2020 | Kollintzas Dean G | Director | Buy(P) | 12K | $5.00 | $60K |
| Sep 29, 2020 | Reynolds Mark | CFO | Buy(P) | 60K | — | $0 |
| Sep 29, 2020 | Chase Randal D | Director | Buy(P) | 17K | — | $0 |
| Sep 29, 2020 | Dodd David A | President, CEO, Director | Buy(P) | 82K | — | $0 |
| Sep 29, 2020 | Dodd David A | President, CEO, Director | Buy(P) | 82K | $5.00 | $409K |
| Sep 29, 2020 | Chase Randal D | Director | Buy(P) | 17K | $5.00 | $83K |
| Sep 29, 2020 | McNally Robert T | Director | Buy(P) | 54K | $5.00 | $270K |
| Sep 29, 2020 | Spencer John N JR | Director | Buy(P) | 21K | — | $0 |
| Sep 29, 2020 | Reynolds Mark | CFO | Buy(P) | 60K | $5.00 | $301K |
| Sep 29, 2020 | Spencer John N JR | Director | Buy(P) | 21K | $5.00 | $105K |
| Sep 29, 2020 | Kollintzas Dean G | Director | Buy(P) | 12K | — | $0 |
| Dec 17, 2018 | Spencer John N JR | Director | Grant(A) | 345K | — | $0 |
| Dec 17, 2018 | McNally Robert T | Director | Grant(A) | 650K | — | $0 |
| Dec 17, 2018 | Kollintzas Dean G | Director | Grant(A) | 300K | — | $0 |
| Dec 17, 2018 | Chase Randal D | Director | Grant(A) | 320K | — | $0 |
| Dec 17, 2018 | Robinson Harriet L | CSO Emeritus, Director | Grant(A) | 600K | — | $0 |
| Dec 17, 2018 | Reynolds Mark | CFO | Grant(A) | 750K | — | $0 |
| Dec 17, 2018 | Guirakhoo Farshad | Chief Scientific Officer | Grant(A) | 625K | — | $0 |
| Dec 17, 2018 | Dodd David A | President, CEO, Director | Grant(A) | 785K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: GeoVax Labs, Inc., SEC CIK 0000832489. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under GOVX and shows every filing by that issuer (also filed as GOVX.OB).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for GOVX